VANCOUVER, BC, May 29, 2024 – Revitalist Lifestyle and Wellness Ltd. (the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) announces that the joint venture agreement dated March 10, 2023, as amended (the “JV Agreement”), between Revitalist LLC (“Revitalist”), its Tennessee subsidiary, and GCM Partners, LLC (“GCM”) has been terminated by GCM. Under the JV Agreement, […]
Comprehensive Psychedelic Wellness Program Combines National and International care with a focus on consistency of standards, evidenced-based protocols and support for all participants through preparation, experiential, and integrative therapies. VANCOUVER, BC, May 29, 2024 – Revitalist Lifestyle and Wellness Ltd. (the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is pleased to announce that its Tennessee […]
VANCOUVER, BC, April 11, 2023 — REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4D0O) announces an exciting joint-venture partnership where Revitalist will gain access to five new locations in Chicago, IL (2), Orlando, FL (2), and Miami, FL. These centrally located offices will now be able to serve […]
(CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into an agreement with Revitalist to participate in their Behavioral Health Network. This relationship will allow Revitalist to access many more patients to extend care for Behavioral Health. Furthermore, Revitalist is also pleased in announce a new COO Paul Auchterlonie. Paul Auchterlonie brings three decades of […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), announces the closing of a non-brokered private placement. This funding will allow Revitalist to start extending its proprietary telemedicine platform across 28 states, with the goal of giving access to more than 50M individuals living with mental […]
Managements in the neuropharmaceutical psychedelics space are upbeat ahead of near-term catalysts. Earlier this month, we met with most of the managements in our coverage universe of companies pursuing psychoactive agents for various mood disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD), among others. Collectively, the teams expressed optimism regarding their lead compounds […]
Revitalist to launch first treatments for those suffering from Alcohol Use Disorder with Awakn’s revolutionary Kare treatment VANCOUVER, BC, December 19, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), is partnering with Awakn’s Prof. David Nutt to discuss ketamine-assisted therapy for Veterans suffering with Addictions in […]
VANCOUVER, BC, November 14, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE:4DO), Revitalist and WAKE Network, Inc. announce the joint venture partnership opening psychedelic clinics and retreats with vertical offerings with a personalized medicine and therapy approach. Revitalist continues to establish its presence as a first full-service […]
VANCOUVER, BC, November 7, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CEO Kathryn Walker awarded Microdose’s “Professional Service Practitioner of the Year”, following last year’s win of “Entrepreneur of the Year” in 2021 at Wonderland: Miami, the largest psychedelic medicine business event. “I am honored […]
VANCOUVER, BC, November 2, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic medicine outcomes. Through a proprietary blend of vitamins, anti-inflammatories and known cognitive enhancing ingredients, Revive+ and Restore+ have been formulated to enhance psychedelic therapy. […]
